Ana López-Machado

2.5k citations
12 papers · 1.8k indexed · 1 hit paper · h-index 11
Topics
Nanoparticle-Based Drug Delivery (3 papers)Advancements in Transdermal Drug Delivery (2 papers)Pediatric health and respiratory diseases (2 papers)
Partner nations
SpainPortugalItaly

In The Last Decade

Ana López-Machado

12 papers receiving 1.8k citations

Hit Papers

Metal-Based Nanoparticles as Antimicrobial Agents: An Ove...202020262022202420202505007501000

Peers

Ana López-Machado
Comparison fields: 5 of 131
  • Materials Chemistry 645
  • Biomedical Engineering 422
  • Biomaterials 371
  • Molecular Biology 317
  • Pharmaceutical Science 265
Replace Mas Jaffri Masarudin with:
Mas Jaffri Masarudin Malaysia
Mohammed F. Aldawsari Saudi Arabia
Lorena Bonilla Spain
Ruth Galindo Spain
Gerard Esteruelas Spain
Miguel Pereira‐Silva Portugal
Sabya Sachi Das India
Subramaniam Sadhasivam India
Sabna Kotta Saudi Arabia
Carolina Alves dos Santos Brazil
Ana López-Machado relative to Mas Jaffri Masarudin Malaysia Mas Jaffri Masarudin's profile →
Citations per field
00.5×1.5×
Mas Jaffri Masarudin · 1×
Citations per year

Countries citing papers authored by Ana López-Machado

Since Specialization
Citations

This map shows the geographic impact of Ana López-Machado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana López-Machado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana López-Machado more than expected).

Fields of papers citing papers by Ana López-Machado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana López-Machado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana López-Machado. The network helps show where Ana López-Machado may publish in the future.

Co-authorship network of co-authors of Ana López-Machado

This figure shows the co-authorship network connecting the top 25 collaborators of Ana López-Machado. A scholar is included among the top collaborators of Ana López-Machado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana López-Machado. Ana López-Machado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 6
2 55
3 31
4
Metal-Based Nanoparticles as Antimicrobial Agents: An Overviewbreakdown →
1020
5 57
6 15
7 83
8 178
9 140
10 53
11 58
12 127

About Ana López-Machado

Ana López-Machado is a scholar working on Pharmaceutical Science, Applied Microbiology and Biotechnology and Emergency Medical Services, having authored 12 papers that have together received 1.8k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (3 papers), Advancements in Transdermal Drug Delivery (2 papers) and Pediatric health and respiratory diseases (2 papers). The work is most often cited by research in Pharmaceutical Science (265 citations), Biomaterials (371 citations) and Molecular Medicine (98 citations). Ana López-Machado has collaborated with scholars based in Spain, Portugal and Italy. Frequent co-authors include Eliana B. Souto, María L. García, Elena Sánchez‐López, Marta Espina, Amanda Cano, Miren Ettcheto, Antoni Camins, Amélia M. Silva, Antonello Santini and Ruth Galindo. Their work appears in journals such as International Journal of Molecular Sciences, International Journal of Pharmaceutics and Colloids and Surfaces B Biointerfaces.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026